查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1750861

呼吸道疫苗市场规模、份额、趋势分析报告（按类型、感染疾病、年龄层、分销管道、地区、细分市场预测），2025 年至 2030 年

Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report By Type (Viral, Bacterial, Combination), By Infection (COVID-19, Influenza), By Age Group, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

呼吸道疫苗市场的成长与趋势

根据Grand View Research, Inc.的最新报告，呼吸道疾病疫苗市场规模预计到2030年将达到703亿美元，2025年至2030年期间的复合年增长率为2.90%。

呼吸道疾病疫苗市场的成长归因于人们对疫苗接种重要性的认识不断提高、呼吸道感染疾病发病率不断上升以及疫苗技术的进步。此外，新冠疫情大大提升了呼吸道疫苗的重要性，进一步加速了市场的发展。

呼吸道疫苗，尤其是流感和肺炎的疫苗，对于减轻医疗系统负担并最大程度降低与 COVID-19 合併感染的风险至关重要。为了防止病毒传播和疫情爆发，医疗保健提供者正致力于接种疫苗，以保护个人免受流感等呼吸道病原体的侵害。过去几年，由于疫苗技术的进步，尤其是针对 SARS-CoV-2 疫苗的研发，呼吸道疫苗市场经历了显着成长。 COVID-19 疫苗的成功研发、核准和部署，证明了科学界快速应对呼吸道威胁的能力，并为未来呼吸道疫苗研发的进步铺平了道路。

此外，国家和全球层面的政府支持和监督，以监测流感疫苗的供应、普及和实施情况，是推动市场成长的关键因素。此外，知名主要企业加大投资，专注于将新型疫苗引入市场，也促进了市场的成长。例如，辉瑞已宣布计划于2022年9月启动其基于mRNA的流感疫苗的第三期临床试验。预计试验将在美国招募2.5万名18岁及以上的受试者。

此外，参与研发和配製各种呼吸道疾病疫苗的主要公司正致力于合作和伙伴关係，以开发新型疫苗并保持市场竞争力。此外，人们对植物来源提供的天然疗法日益增长的兴趣预计将在预测期内推动市场发展。此外，为了满足日益增长的药品需求，许多公司正在进行地理扩张和分销。例如，辉瑞公司于2023年5月获得美国食品药物管理局（FDA）核准其呼吸道合胞病毒（RSV）疫苗ABRYSVO，用于预防60岁及以上老年族群由RSV引起的下呼吸道疾病。

呼吸道疾病疫苗市场报告重点

  • 根据类型，由于病毒性呼吸道疾病的盛行率不断上升，病毒疫苗领域在 2024 年占据最大的市场占有率，为 54.84%。
  • 根据年龄组，由于儿童疫苗配方的增加，预计预测期内儿科领域将出现最快的成长率。
  • 按感染疾病，由于对开发疫苗以阻止 COVID-19 病毒传播的需求日益增加，COVID-19 领域在 2024 年占据了最大的市场占有率，为 40.03%。
  • 市场上的主要企业不断专注于地理扩张和产品发布，以维持其存在。
  • 由于主要参与者的存在、医疗保健基础设施的不断提高、慢性病病例的增加以及充足的疫苗接种服务的可用性，预计北美呼吸道疾病疫苗市场将在预测期内出现强劲增长。

目录

第一章调查方法与范围

第二章执行摘要

3. 呼吸道疫苗市场变数、趋势与范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 呼吸道疾病疫苗市场分析工具
    • 波特分析
    • PESTEL分析

第四章呼吸道疾病疫苗市场：按类型估计和趋势分析

  • 细分仪表板
  • 呼吸道疾病疫苗市场：2024 年和 2030 年类型变化分析
  • 病毒疫苗
  • 细菌疫苗
  • 联合疫苗

第五章呼吸道疾病疫苗市场：依年龄组别估计及趋势分析

  • 细分仪表板
  • 呼吸道疫苗市场：2024 年和 2030 年年龄层趋势分析
  • 孩子们
  • 成人

第六章呼吸道疾病疫苗市场：感染疾病的估计与趋势分析

  • 细分仪表板
  • 呼吸道疫苗市场：2024 年和 2030 年感染疾病趋势分析
  • COVID-19
  • 流感
  • 呼吸道融合细胞病毒（RSV）
  • 肺炎
  • 其他的

第七章呼吸道疾病疫苗市场：按分销管道的估计和趋势分析

  • 细分仪表板
  • 呼吸道疾病疫苗市场：2024 年及 2030 年通路变化分析
  • 医院和药房
  • 政府供应商
  • 其他的

第八章呼吸道疾病疫苗市场：按地区估计和趋势分析

  • 2024 年及 2030 年呼吸道疫苗市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • GSK plc.
    • Johnson &Johnson Services, Inc.
    • Pfizer Inc.
    • Sanofi
    • Serum Institute of India Pvt. Ltd.
    • SINOVAC
    • Bavarian Nordic
    • Merck &Co., Inc.
    • AstraZeneca
    • EMERGENT
    • Novavax
    • INOVIO Pharmaceuticals
    • Moderna, Inc.
Product Code: GVR-4-68040-093-9

Respiratory Disease Vaccine Market Growth & Trends:

The respiratory disease vaccine market size is estimated to reach USD 70.30 billion by 2030, expanding at a CAGR of 2.90% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the respiratory disease vaccine market is attributable to increasing awareness associated with the importance of vaccination, the rising incidence of respiratory infections, and advancements in vaccine technology. Moreover, the COVID-19 pandemic has brought significant traction to the importance of respiratory vaccines which has further accelerated the market.

Respiratory vaccines, particularly those targeting influenza and pneumonia, are vital in reducing the burden on healthcare systems and minimizing the risk of co-infections with COVID-19. In order to prevent the spread of the virus and prevent the occurrence of outbreaks healthcare providers have been focusing on vaccination to protect individuals against respiratory pathogens like influenza. In recent years, the respiratory vaccine market has witnessed substantial growth attributed to advancements in vaccine technology, specifically in the development of vaccines targeting SARS-CoV-2. The successful development, approval, and deployment of COVID-19 vaccines have demonstrated the capacity of the scientific community to respond rapidly to respiratory threats and have paved the way for future advancements in respiratory vaccine research and development.

Moreover, government backing and surveillance at both national and global levels to monitor the availability, dissemination, and implementation of influenza vaccines is a crucial factor driving the growth of the market. Additionally, increased investments by prominent key players with a major focus on the introduction of novel vaccines into the market have contributed to the growth of the market. For instance, Pfizer recently disclosed their plans to commence Phase 3 clinical trials for their mRNA-based influenza vaccine in September 2022. This trial will involve a cohort of 25,000 individuals aged 18 and above from the U.S.

Furthermore, key players involved in developing and formulating various respiratory disease vaccines are focusing on collaborations and partnerships to develop novel vaccines and to maintain their competitive position in the market. In addition, increasing interest in plant-based medicines owing to natural remedies offered by them is expected to boost the market over the forecast period. Moreover, a number of players are involved in geographic expansion and distribution to meet the rising demand for medicinal products. For instance, in May 2023, Pfizer Inc. received FDA approval for ABRYSVO, a RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in the elderly population above the age of 60 years.

Respiratory Disease Vaccine Market Report Highlights:

  • Based on type, the viral vaccine segment held the largest market share of 54.84% in 2024 owing to the increasing prevalence of viral respiratory conditions
  • Based on age group, the pediatric segment is expected to show the fastest growth rate over the forecast period owing to the rising formulation of vaccines for the pediatric population
  • On the basis of infection, The COVID-19 segment held the largest market share of 40.03% in 2024 due to the growing need for the development of a vaccine to stop the spread of the COVID-19 virus
  • Key players operating in the market are constantly focusing on geographical expansion and product launches to maintain their presence
  • North America's respiratory disease vaccine market is expected to grow strongly over the forecast period which can be attributed to the presence of key players, rising healthcare infrastructure, growing cases of chronic disorders, and availability of proper vaccination service

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Respiratory Disease Vaccine Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Respiratory Disease Vaccine Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Respiratory Disease Vaccine Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Respiratory Disease Vaccine Market: Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Viral Vaccine
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Bacterial Vaccine
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Combination Vaccine
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Respiratory Disease Vaccine Market: Age Group Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Respiratory Disease Vaccine Market: Age Group Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Pediatric
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Adult
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Respiratory Disease Vaccine Market: Infection Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Respiratory Disease Vaccine Market: Infection Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. COVID-19
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Influenza
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Respiratory Syncytial Virus (RSV)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Pneumonia
    • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Respiratory Disease Vaccine Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Respiratory Disease Vaccine Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
  • 7.3. Hospital & Retail Pharmacies
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Government Suppliers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Respiratory Disease Vaccine Market: Regional Estimates & Trend Analysis

  • 8.1. Respiratory Disease Vaccine Market Share, By Region, 2024 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. South Africa Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Respiratory Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. GSK plc.
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Johnson & Johnson Services, Inc.
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Pfizer Inc.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Sanofi
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Serum Institute of India Pvt. Ltd.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. SINOVAC
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Bavarian Nordic
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Merck & Co., Inc.
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. AstraZeneca
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. EMERGENT
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives
    • 9.4.11. Novavax
      • 9.4.11.1. Participant's Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Recent Developments/ Strategic Initiatives
    • 9.4.12. INOVIO Pharmaceuticals
      • 9.4.12.1. Participant's Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Recent Developments/ Strategic Initiatives
    • 9.4.13. Moderna, Inc.
      • 9.4.13.1. Participant's Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Respiratory Disease Vaccine Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 6 Global Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 7 Global Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 8 North America Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 11 North America Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 12 North America Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 U.S. Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 15 U.S. Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 16 U.S. Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Canada Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 19 Canada Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 20 Canada Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 Mexico Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 23 Mexico Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 24 Mexico Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 Europe Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 28 Europe Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 29 Europe Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 Germany Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 32 Germany Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 33 Germany Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 UK Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 UK Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 36 UK Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 37 UK Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 France Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 France Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 40 France Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 41 France Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Italy Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Italy Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 44 Italy Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 45 Italy Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Spain Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 48 Spain Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 49 Spain Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Denmark Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Denmark Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 52 Denmark Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 53 Denmark Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Sweden Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Sweden Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 56 Sweden Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 57 Sweden Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Norway Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 59 Norway Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 60 Norway Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 61 Norway Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 Japan Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 Japan Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 69 Japan Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 70 Japan Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71 China Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 China Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 73 China Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 74 China Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 India Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 India Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 77 India Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 78 India Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 South Korea Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 81 South Korea Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 82 South Korea Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Australia Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Australia Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 85 Australia Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 86 Australia Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Thailand Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 88 Thailand Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 89 Thailand Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 90 Thailand Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 Latin America Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 Latin America Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 94 Latin America Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 95 Latin America Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 96 Brazil Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 97 Brazil Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 98 Brazil Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 99 Brazil Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 100 Argentina Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 102 Argentina Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 103 Argentina Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 113 South Africa Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 114 South Africa Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 115 South Africa Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 116 South Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 117 UAE Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 119 UAE Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 120 UAE Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Respiratory disease vaccine market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Respiratory disease vaccine market: Type outlook key takeaways
  • Fig. 20 Respiratory disease vaccine market: Type movement analysis
  • Fig. 21 Viral vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Bacterial vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Combination vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Respiratory disease vaccine market: Age Group outlook key takeaways
  • Fig. 25 Respiratory disease vaccine market: Age Group movement analysis
  • Fig. 26 Pediatric market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Adult market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Respiratory disease vaccine market: Infection outlook key takeaways
  • Fig. 29 Respiratory disease vaccine market: Infection movement analysis
  • Fig. 30 COVID-19 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Influenza market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Respiratory Syncytial Virus (RSV) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Pneumonia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Respiratory disease vaccine market: Distribution Channel outlook key takeaways
  • Fig. 36 Respiratory disease vaccine market: Distribution Channel movement analysis
  • Fig. 37 Hospital & Retail Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Government Suppliers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Regional marketplace outlook, 2024 & 2030 (USD million)
  • Fig. 41 Regional marketplace: Key takeaways
  • Fig. 42 North America Respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 U.S. Respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Canada respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Mexico respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 UK respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Germany respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 France respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Spain respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Italy respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Denmark respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Sweden respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Norway respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Japan respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 China respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 India respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Australia respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Korea respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Thailand respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Latin America respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Argentina respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Middle East & Africa respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 UAE respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Kuwait respiratory disease vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Market participant categorization
  • Fig. 89 respiratory disease vaccine market position analysis, 2024
  • Fig. 90 Strategic framework